Document is current
Any future updates will be listed below
-
Authors
Peng, Xinyi
Olsen, Michael Hecht
Pareek, Manan
Bai, Jingjing
Liu, Yang
Song, Qirui
Cai, Jun
-
Funding
Funding for this research was provided by:
China Postdoctoral Science Foundation (2023M740322)
Postdoctoral Fellowship Program of CPSF (GZC20240148)
CAMS Innovation Fund for Medical Sciences (CIFMS, 2021-I2M-1-007)
National High Level Hospital Clinical Research Funding (2022-GSP-GG-5)
- License Information
-
More Information
Article History
Received: 12 October 2024
Accepted: 20 May 2025
First Online: 1 July 2025
Declarations
:
: The study was approved by the Ethics Committee of Fuwai Hospital (approval number: 2016–838) and all collaborating centres and was conducted in accordance with the principles of the Declaration of Helsinki. All the participants provided written informed consent.
: Not applicable.
: Prof. Manan Pareek has served on advisory boards for AstraZeneca, Janssen-Cilag, and Novo Nordisk. He has received grant support from the Danish Cardiovascular Academy, funded by the Novo Nordisk Foundation and the Danish Heart Foundation (grant number: CPD5Y-2022004-HF). Additionally, he has received speaker honoraria from AstraZeneca, Bayer, Boehringer Ingelheim, and Janssen-Cilag. Prof. Michael Hecht Olsen has received speaker honoraria from Novo Nordisk A/S, Teva A/S, and AstraZeneca A/S. Additionally, Prof. Olsen has been the recipient of research grants from the Danish Heart Foundation and the Novo Nordisk Foundation.
